Compare Pool Advista Indonesia Tbk. (POOL) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pool Advista Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Pool Advista Indonesia Tbk. trades at Rp50 (market cap 117.07B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Pool Advista Indonesia Tbk. and Organon Pharma Indonesia Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| POOL | SCPI | |
|---|---|---|
Market Cap | 117.07B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pool Advista Indonesia Tbk.
PT Pool Advista Indonesia Tbk (formerly PT. Pool Asuransi Indonesia Tbk) was established on August 16, 1958 based on the notarial deed of Meester Liem Hie Thaij No.86, the changes of notarial of Anwar Mahajudin. The notarial deed was approved by the Ministry of Justice in his decision letter No.J.A5/104/10 dated December 1, 1958 and was published on State Gazette No. 55, Supplement No. 332 dated July 11, 1961. The Company has branches in Medan, Pekanbaru, Bandar Lampung, Bogor, Cirebon, Surabaya and Samarinda.
Read more on POOL →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
